Portfolio Services Ltd.'s Net Worth
$0
Estimate Recalculated May 30, 2025 08:59PM EST
Who is Portfolio Services Ltd.?
Portfolio Services Ltd. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include AASTROM BIOSCIENCES INC, PEREGRINE PHARMACEUTICALS INC, Cyclacel Pharmaceuticals, Inc., iBio, Inc., TAPIMMUNE INC, and CYTOKINETICS INC.
SEC CIK
Portfolio Services Ltd.'s CIK is 0001488856
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AASTROM BIOSCIENCES INC (VCEL) Snapshot price: $45.22
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +85.30% | 362.5K |
$4.80 | $1,740,000.00 | 787.49K |
Jul 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PEREGRINE PHARMACEUTICALS INC (CDMO) Snapshot price: $9.25
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cyclacel Pharmaceuticals, Inc. (CYCC) Snapshot price: $1.02
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +64.53% | 850K |
$2.00 | $1,700,000.00 | 2.17M |
Jul 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
iBio, Inc. (IBIO) Snapshot price: $1.78
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +105.98% | 4.44M |
$1.74 | -$74,160,683.17 | 8.63M |
Aug 7 - Aug 11
| |||
Form 4
| -11.42% | -4.27M |
$4.27 | -$18,220,725.85 | 33.11M |
Aug 4 - Aug 6
| |||
Form 4
| +35.16% | 2.2M |
$0.90 | $1,980,000.00 | 8.46M |
Jul 12
| |||
Form 4
| +36.80% | 1.68M |
$0.90 | $1,515,000.60 | 6.26M |
Jun 26
| |||
Form 4
| +35.56% | 12M |
$0.20 | $2,400,000.00 | 45.74M |
Nov 30
| |||
Form 4
| +23.86% | 6.5M |
$0.62 | $4,043,000.00 | 33.74M |
Apr 7
| |||
Form 4
| +24.06% | 5.28M |
$0.59 | $3,122,520.00 | 27.24M |
Jan 25
| |||
Form 4/A
| +51.87% | 7.5M |
$0.40 | $3,000,000.00 | 21.96M |
Oct 15
| |||
Form 4
| +44.60% | 4.46M |
—
|
—
| 14.46M |
Apr 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Marker Therapeutics, Inc. (MRKR) Snapshot price: $3.17
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
| +11.47% | 416.67K |
$1.20 | $500,000.40 | 4.05M |
Feb 18
| |||
Form 4
| +32.50% | 1.3M |
$2.40 | $3,120,000.00 | 5.3M |
May 14
| |||
Form 4
| +40.00% | 8M |
$0.50 |
—
| 28M |
Aug 10
| |||
Form 4
| +100.00% | 10M |
$0.20 | $2,000,000.00 | 20M |
Sep 9
| |||
Form 4
| +100.00% | 5M |
$0.50 | $2,500,000.00 | 10M |
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||